Incremental Cost-Effectiveness Ratio
The interactive online graph shows the region (shaded green) for therapies deemed cost-effective given a particular cost-effectiveness threshold. What happens to the cost-effectiveness of a therapy if you decrease its incremental effectiveness (measured in QALYs)? What happens if you lower its incremental cost?
